Home > Insider Trading > Filing (0001209191-18-063579)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192591	J Charles Homcy	C/O Portola Pharmaceuticals, Inc. 270 East Grand Ave. South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-17	64,218	$4.10	176,689	No	4	M	Direct
Common Stock	Disposition	2018-12-17	63,518	$18.60	113,171	No	4	S	Direct
Common Stock	Disposition	2018-12-17	700	$19.20	112,471	No	4	S	Direct
Common Stock	Acquisiton	2018-12-19	25,782	$4.10	119,480	No	4	M	Indirect	Charles Homcy Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Indirect	Charles Homcy Revocable Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-12-17	24,390	$0.00	24,390	$4.10
Common Stock	Stock Option (Right to Buy)	Disposition	2018-12-17	39,828	$0.00	39,828	$4.10
Common Stock	Stock Option (Right to Buy)	Disposition	2018-12-19	25,782	$0.00	25,782	$4.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-12-23	2018-12-22	No	4	M	Direct
25,782	2008-12-23	2018-12-22	No	4	M	Direct
0	2008-12-23	2018-12-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	The Charles J. Homcy 2009 Grantor Retained Annuity Trust

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.2000 to $19.1900, inclusive.
These sales were sold in a single transaction at a price of $19.20.
Dr. Homcy exercised these shares through a cash exercise and transferred the shares following the exercise into the Charles Homcy Revocable Trust for which Dr. Homcy is a trustee.